Mevlyq

Medicinal product

(Invented) name

Mevlyq

Active substance (s)

Eribulinas

Strength

0,44 mg/ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01XX41, Eribulin

Marketing authorisation holder

YES Pharmaceutical Development Services GmbH, Vokietija

Date of authorisation

2024-02-09

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Solution for injection	1 ml
Eribulinas	0,44 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
112904	99022	1099022	flakonas	2 ml N1		Receptinis	EU/1/23/1789/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-02-09	Registruotas